Table 1.
Baseline characteristics of the triptorelin 3-month depot and 1-month depot subjects
| Variable | TP 3-mo (n=29) | TA 1-mo (n=40) | P-value |
|---|---|---|---|
| Age (yr) | 8.6±0.4 | 8.5±0.5 | 0.274 |
| Midparental height (cm) | 160.8±3.6 | 160.9±3.8 | 0.920 |
| Height (cm) | 135.4± 4.7 | 135.1±4.6 | 0.795 |
| Height SDS for CA | 0.9±0.8 | 1.0±0.5 | 0.559 |
| Weight (kg) | 33.7±5.7 | 34.5±4.8 | 0.513 |
| BMI (kg/m2) | 18.3±2.5 | 18.9±2.1 | 0.292 |
| BMI SDS for CA | 0.6±1.2 | 1.0±1.0 | 0.202 |
| BA (yr) | 10.4±0.4 | 10.3±0.6 | 0.491 |
| BA–CA (yr) | 1.8±0.4 | 1.8±0.4 | 0.723 |
| GnRH-stimulated LH peak (IU/L) | 17.5±12.9 | 15.2±14.5 | 0.503 |
| GnRH-stimulated FSH peak (IU/L) | 14.4±12.0 | 16.7±6.6 | 0.312 |
| Estradiol (pg/mL) | 0.8±4.4 | 2.1±3.1 | 0.176 |
| Predicted adult height (cm) | 159.5±5.3 | 159.4±2.9 | 0.908 |
Values are presented as mean±standard deviation.
TP 3-mo, triptorelin pamoate 3-month depot; TA 1-mo, triptorelin acetate 1-month depot; SDS, standard deviation score; CA, chronological age; BMI, body mass index; BA, bone age; GnRH, gonadotropin-releasing hormone; LH, luteinizing hormone; FSH, follicle-stimulating hormone.